CEO Interview - FY results
Filed with ASX · · 5 pages · English
Summary by 6ix AI
This filing is an interview with Dr. Sam Hupert, CEO of Pro Medicus, discussing the company's full-year results and growth prospects. The interview highlights record revenue and profit growth, driven by strong performance in North America and new contract wins. Dr. Hupert emphasizes the scalability of their business model and the strategic advantages of their cloud-based solutions. The company plans to continue investing in growth opportunities, including potential mergers and acquisitions.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
In the deck
Story so far
Earlier from Pro Medicus
- Preliminary Final Report
- PME signs five new deals with a combined minimum of A$45M
- Macquarie Conference May 2024 Presentation
- S&P DJI Announces March 2024 Quarterly Rebalance
- Cancel - Notification of buy-back - PME
Later from Pro Medicus
- PME FY2024 results presentation
- PME signs A$98M, 8 year contract renewal with Mercy Health
- PME signs $32M, 5-year contract extension in Australia
- AGM 2024 - Presentation
- PME signs $24M upgrade to Full Stack with NYU Langone Health
Follow Pro Medicus into a list and get an email when it puts out news.
Follow Pro Medicus